Tokyo Hiroo Metropolitan General Hospital

Tokyo, Japan

Tokyo Hiroo Metropolitan General Hospital

Tokyo, Japan
SEARCH FILTERS
Time filter
Source Type

Abe S.,Tokyo Hiroo Metropolitan General Hospital
Japanese Journal of Chest Diseases | Year: 2014

Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF), or AE-IPF, has been increasingly recognized as a critical event in the clinical course of IPF. AE-IPF is pathologically characterized by diffuse alveolar damage (DAD), which is also observed in acute respiratory distress syndrome (ARDS). Current therapies, including high-dose corticosteroid and immunosuppressive agents, provide little benefit for the poor prognosis in AE-IPF. Recent reports have suggested beneficial effects of anti-coagulant therapy and PMX (polymyxin B-immobilized fiber) treatment in patients with AE-IPF.

Loading Tokyo Hiroo Metropolitan General Hospital collaborators
Loading Tokyo Hiroo Metropolitan General Hospital collaborators